London based health tech startup secures $11m investment
A UK and US health tech startup has announced that it has secured $11m of funding.
Quit Genius, which has its UK headquarters in London, has received the investment from a Series A funding round led by Octopus Ventures.
Hubert Burda Media’s international growth capital arm BurdaPrincipal Investments joined the round along with Y Combinator, Startup Health, and Triple Point Ventures.
The company uses cognitive behavioural therapy aims to aid users in quitting smoking and vaping tobacco products.
Quit Genius is expected to use the funding to expand into other types of addiction, including alcohol and opioid addiction.
Amelia Townsend, principal at BurdaPrincipal Investments, commented: “At BPI we are working in-depth into the health tech space.
“We are delighted to join the Quit Genius team and our fellow investors and are looking forward to being part of the journey!”
Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular morning London email for free.
Keeping it reel: Creating video in an authenticity era
Budget: Creating a more vibrant market economy
Celebrating excellence and community support
The value of nurturing homegrown innovation
A dynamic, fair and innovative economy
Navigating the property investment market
Have stock markets peaked? Tune out the noise
Will the Employment Rights Bill cost too much?
A game-changing move for digital-first innovators
Confidence the missing ingredient for growth
Global event supercharges North East screen sector
Is construction critical to Government growth plan?